A broad array of chemically diverse antibiotic compounds inhibit bacterial protein synthesis by targeting functional centers within the 2.4-MDa ribosome particle, an RNA-protein complex that is composed of a small (30S) and a large (50S) subunit [1] [2] [3] . A majority of these compounds operate by altering messenger RNA (mRNA) and tRNA interactions within the decoding, peptidyl transferase and GTPase centers of the small and large ribosomal subunits 4, 5 . Despite the effectiveness of such compounds in the clinical treatment of infectious disease, the growing prevalence of pathogens resistant to these agents 6-8 has created a pressing need to identify new target sites in the ribosome with alternative modes of action that can be leveraged for the regulation of the translation machinery 9,10 . In pursuit of this goal, we used single-molecule fluorescence and X-ray crystallographic methods to gain a deeper understanding of the mechanisms by which aminoglycoside-class antibiotics inhibit bacterial translation.
a r t i c l e s
A broad array of chemically diverse antibiotic compounds inhibit bacterial protein synthesis by targeting functional centers within the 2.4-MDa ribosome particle, an RNA-protein complex that is composed of a small (30S) and a large (50S) subunit [1] [2] [3] . A majority of these compounds operate by altering messenger RNA (mRNA) and tRNA interactions within the decoding, peptidyl transferase and GTPase centers of the small and large ribosomal subunits 4, 5 . Despite the effectiveness of such compounds in the clinical treatment of infectious disease, the growing prevalence of pathogens resistant to these agents [6] [7] [8] has created a pressing need to identify new target sites in the ribosome with alternative modes of action that can be leveraged for the regulation of the translation machinery 9, 10 . In pursuit of this goal, we used single-molecule fluorescence and X-ray crystallographic methods to gain a deeper understanding of the mechanisms by which aminoglycoside-class antibiotics inhibit bacterial translation.
Aminoglycoside antibiotics in the 2-deoxystreptamine (2-DOS) family are broad-spectrum bactericidal agents that are used to treat Gram-negative bacterial infections. In vivo, these compounds have been shown to allosterically alter the mechanism of aa-tRNA selection during mRNA decoding on the ribosome [11] [12] [13] by inducing local rearrangements in ribosomal RNA (rRNA) within the highly conserved helix 44 (h44) decoding site of the small (30S) subunit. Thus, 2-DOS aminoglycosides promote the inappropriate incorporation of near-cognate aa-tRNA (one mismatch with the mRNA codon) and noncognate aa-tRNAs (two or three mismatches with the mRNA codon) into the aminoacyl (A) tRNA binding site. Increased aa-tRNA misincorporation is thought to eventually exceed the capacity of the cell to cope with decreased translational fidelity 14 , ultimately resulting in cell death 15 . However, as reductions in translation fidelity alone typically have little effect on cell growth 1, 16 , the bactericidal nature of the action of 2-DOS aminoglycosides remains poorly understood.
In vitro, 2-DOS aminoglycosides also inhibit a range of distinct steps in the translation mechanism. These include mRNA and tRNA translocation, the directional movement of substrates with respect to both subunits of the intact (70S) ribosome 1, 17 and ribosome recycling, the process of subunit separation after the termination phase of protein synthesis 18 . Although the physical origins of these aminoglycoside-induced effects are unclear, early biochemical studies revealed that aminoglycosides can bind to regions of the ribosome that are outside the canonical mRNA decoding site 19, 20 . Recently, the aminoglycoside neomycin (Fig. 1a) was shown crystallographically to bind to the bacterial ribosome within H69 of 23S rRNA in the large (50S) subunit 21 . Binding at this site was hypothesized to provide a potential explanation for the inhibition of both ribosome recycling and substrate (mRNA and tRNA) translocation 17, 21 .
Large-scale conformational changes within the ribosome contribute to every aspect of the translation cycle: initiation, elongation, termination and recycling 22 . Rearrangements at the subunit interface have been implicated in the joining of large and small subunits during initiation and the positioning of tRNA substrates during processive elongation reactions, as well as the binding of translation factors during termination and the release of the protein products 23, 24 .
Conformational plasticity of the centrally located intersubunit bridge B2, formed by the interaction of H69 of the large subunit with h44 of the small subunit, has been posited to function as a potential regulator of translation processes 25, 26 . Recently reported ribosome structures have revealed that remodeling in this region-immediately proximal to the tRNA and mRNA binding sites-facilitates rotation of the small subunit with respect to the large subunit. This axis of movement affects almost every aspect of the translation mechanism 27 . Here, using a combination of single-molecule fluorescence and X-ray crystallographic methods 27 , we show that global inhibition of translation can be induced by neomycin through its specific interaction with H69 of the large subunit. Binding at this site allows the drug to allosterically control ribosome dynamics in a manner that affects multiple aspects of the translation mechanism.
RESULTS

Neomycin activities beyond the mRNA decoding site
Selection of cognate compared to near-cognate tRNA in mRNA decoding involves multiple kinetic steps that result in the accommodation of aa-tRNA into the ribosomal A site 14, 28 . To probe the effects of neomycin on mRNA decoding, we used pre-steady state single-molecule fluorescence resonance energy transfer (smFRET) to measure the rate and extent of aa-tRNA incorporation into the A site 29 as a function of neomycin concentration. In line with the propensity of neomycin to induce translational miscoding 10, 30 , these smFRET measurements showed that low concentrations of neomycin (100 nM) substantially increased the rates of near-cognate aa-tRNA accommodation into the ribosomal A site (Fig. 1b) . As expected from the results of the earlier studies, neomycin had negligible effects on the selection of cognate tRNA (Fig. 1b) .
We did not find any evidence of neomycin-induced miscoding when we examined ribosomes containing the well-established A1408G resistance mutation in 16S rRNA (Supplementary Fig. 1a) , which abrogates neomycin binding to the h44 decoding site 31 . However, when we performed identical experiments at a higher concentration of neomycin (20 µM), the selection of both cognate and near-cognate tRNA was strongly attenuated (Fig. 1b) . Notably, the inhibition of both cognate and near-cognate tRNA selection at this elevated concentration of neomycin persisted in the context of the A1408G mutant ribosomes (Supplementary Fig. 1a ). These findings suggest that the inhibition of aa-tRNA accommodation may involve a mechanism that is distinct from the neomycin-induced miscoding that results from binding within h44, where neomycin binds outside of the canonical mRNA decoding site.
In line with previous investigations 17 , single-molecule measurements of substrate translocation 32 showed that neomycin also strongly inhibited the rate and extent of directional substrate movement with respect to the small subunit (Fig. 1c) . Moreover, the neomycininduced translocation inhibition profiles were similar for wild-type and A1408G ribosomes (compare Fig. 1c and Supplementary Fig. 1b) . Neomycin also inhibited ribosome recycling, a process that is mediated by the ribosome recycling factor (RRF) and elongation factor G (EF-G) 33 . Again, the dependence of translocation inhibition on concentration was similar in wild-type and A1408G ribosomes (compare Fig. 1d and Supplementary Fig. 1c) . Together, these findings implicate the binding of neomycin to one or more binding sites outside of the h44 decoding site as being responsible for the inhibition of substrate translocation and ribosome recycling.
Neomycin binding alters small-subunit rotation dynamics
To test whether neomycin inhibits translation by altering global conformational processes in the ribosome, we developed a new smFRET approach for detecting intersubunit rotation and the accompanying process of the formation of an 'unlocked state' , both of which precede, a r t i c l e s and are crucial to, mRNA and tRNA translocation and ribosome recycling 23, 32, 34 . Formation of the unlocked state is achieved through an approximately 9° rotation of the small subunit with respect to the large subunit, which entails numerous rearrangements in key intersubunit bridges, including B2 and B7a 27 . Related to this process, deacylated P-site tRNA also moves from its classical configuration to a hybrid configuration, and the L1 stalk-so named because it contains the L1 protein-compacts toward the subunit interface 23, 27 . Contacts between the 3′ CCA end of tRNA and the large subunit exit (E) site, as well as between the elbow domain of hybrid (P/E) tRNA and the L1 stalk, partially stabilize the unlocked state 27 . Prior investigations revealed that each of these structural processes occur spontaneously in physiological solutions 22 . Consequently, the ribosome transitions into and out of the unlocked state 35, 36 under equilibrium conditions. To probe the occurrence of these events using smFRET techniques, we introduced donor and acceptor fluorophores into peripheral regions of the large and small subunits of the ribosome that come into close proximity in the unlocked state. We did this by site-specifically attaching a Cy5 fluorophore to ribosomal protein L1 (ref. 36) in the large subunit and a Cy3 fluorophore to ribosomal protein S13 located within the small-subunit head domain ( Fig. 2a and Online Methods). Using this labeling strategy, we probed ribosome complexes lacking A-site tRNA and bearing either deacylated P-site tRNA fMet or tRNA Phe , the substrates used in the tRNA selection and recycling studies, respectively.
Consistent with the intrinsically dynamic nature of the ribosome, we found that these ribosome complexes exchanged between two predominant configurations (a low-FRET (0.19 ± 0.01) and a high-FRET (0.55 ± 0.01) (mean FRET values ± s.d.) state) on the subsecond time scale (Supplementary Fig. 2a,b) . As we anticipated from previous investigations of native ribosome complexes 36,37 , we also found evidence of at least one short-lived intermediate-FRET configuration ( Supplementary Fig. 2c-f) . We probed the structural origins of these FRET states using the addition of translation factors known to stabilize distinct ribosome conformations. For example, release factor 1 (RF-1) favors a locked ribosome configuration in which P-site tRNA occupies its classical state (P/P) and the L1 stalk adopts an open position [38] [39] [40] . Consistent with this notion, we found that RF-1 strongly stabilized the low-FRET state (Supplementary Fig. 3a ). In line with the known propensity of both factors to stabilize a rotated configuration of the small subunit and a closed L1 stalk position 23, 34, 41, 42 , RRF and EF-G each stabilized the high-FRET state ( Supplementary Fig. 3b,c) . Together, these studies stipulated that transitions between low-and high-FRET states provide information on the process of small-subunit rotation.
Antibiotic control of subunit rotation dynamics
We next tested whether small-molecule compounds known to alter the translation mechanism also affect subunit rotation dynamics. We first examined the effects of the 4,6-linked, 2-DOS antibiotic kanamycin, which stabilizes deacylated P-site tRNA and peptidyl A-site tRNA in classical configurations within the pre-translocation complex 17 . The effect of kanamycin on the pre-translocation complex has been attributed to its stabilization of interactions between the mRNA codon and the tRNA anticodon in the A site resulting from the drug binding to the h44 decoding site 17, 43 . Notably, although the complexes examined here lack peptidyl A-site tRNA, we did find that kanamycin stabilized the low-FRET ribosome configuration (Supplementary Fig. 3d ). This finding argues that the interactions of kanamycin with h44 restrict the conformational changes that are required for small-subunit rotation. Fig. 3e ). This result is consistent with previous investigations showing that ribosomes favor hybrid (P/E) tRNA and rotated ribosome configurations in the presence of viomycin 45, 46 . The smFRET results obtained here suggest that kanamycin and viomycin stabilize the structurally defined locked and unlocked ribosome configurations, respectively. Together, these observations support the notion that antibiotic-induced remodeling of the small-subunit decoding region can affect the properties of bridge B2 in a manner that has an impact on subunit rotation 17, 27 . Notably, in identical complexes, neomycin exerted a bimodal effect on subunit rotation dynamics (Fig. 2b) . Consistent with the proposed effects of neomycin on binding in the h44 decoding site, the predominant effect of low concentrations of neomycin (<1 µM) was to stabilize the low-FRET, locked ribosome configuration 17 . However, at higher concentrations of neomycin (>1 µM), an intermediate-FRET configuration of the ribosome clearly emerged, whose FRET value (0.37 ± 0.01) fell between those assigned to the locked and unlocked states. Close inspection of the smFRET data revealed that stabilization of the intermediate-FRET state began to emerge even at low concentrations of neomycin (<1 µM). We also observed a similar intermediate-FRET configuration at comparable neomycin concentrations in complexes containing tRNA Phe in the P site (Fig. 2c) . Here, however, the bimodal nature of the effect of neomycin was substantially masked by the inherent propensity of this complex to favor the unlocked state 36 . Collectively, these data argue that neomycin can stabilize an intermediate ribosome configuration that is in transition between the locked and unlocked states 36 . The functional data presented here (Fig. 1) suggest that such a configuration may be incompatible with tRNA selection, translocation and ribosome recycling.
Crystal structure of neomycin-bound recycling complex To gain structural insights into this intermediate ribosome configuration, we used neomycin to soak crystals containing 70S ribosomes in either the unrotated or the fully rotated state and containing bound P/P or P/E deacylated tRNA Phe , respectively 27 . We used these crystals to measure diffraction data to a resolution of 3.5 Å ( Table 1 ). After refinement of the 70S ribosome structures with tRNA removed from the models, we found that electron density maps of the unbiased F obs -F calc difference contained a clear, positive electron density for neomycin. In the unrotated ribosome, neomycin was bound in its canonical h44 decoding site (Supplementary Fig. 4a ). In the rotated ribosome, neomycin was also present in the h44 site. However, we also found unambiguous positive density for neomycin at a site near the base of H69 in the large subunit (Supplementary Fig. 4b ), which is a region of the intersubunit bridge B2 where H69 interacts with helices h24 and h45 of the small-subunit rRNA (Fig. 3a) . In this site, interactions between neomycin and the ribosome bridge the subunit interface such that rings I-III of neomycin contact residues within the H69 major groove and ring IV mediates contacts with h45 of the small subunit (Fig. 3b) .
Neomycin binding to H69 was accommodated by substantial alterations in the extent of the small-subunit rotation. In contrast to the fully rotated state, the overall extent of small-subunit rotation was markedly attenuated (Fig. 3c) . In addition, motions of the small-subunit body along the subunit rotation trajectory were partially uncoupled from those of the platform and head domains. Whereas the small-subunit spur region moved to the same extent as in the fully rotated structure (approximately 20 Å), the small-subunit platform domain in the neomycin-bound state rotated to a lesser extent (approximately 6° compared to 9°). Lateral motions of the small-subunit head domain were also smaller in the neomycin-bound state than in the fully rotated state (approximately 15 Å compared to 20 Å, respectively). The swivel-like Notably, electron density maps of the F obs -F calc difference also placed P-site tRNA in a position that was intermediate between the classical (P/P) and hybrid (P/E) configurations 27, 47 (Fig. 4a,b) . In this new configuration, the tRNA anticodon stem loop maintained the same key interactions within the small-subunit P site in both the unrotated and fully rotated ribosome structures (Supplementary Fig. 4c) . The 3′ CCA terminus of the tRNA also remained within the largesubunit E site 27, 47 (Supplementary Fig. 4d) . However, because of the intermediate extent of small-subunit rotation (Fig. 3c) , the tRNA anticodon was only partially displaced in the direction of translocation (approximately 2 Å compared to 6 Å in the fully rotated state) (Fig. 4b) . The P-site tRNA elbow domain also clearly occupied a position that was intermediate between the classical (P/P) and hybrid (P/E) configurations 27 and that prevented its physical interaction with the L1 stalk in the crystal. In keeping with nomenclature previously established for other intersubunit hybrid tRNA positions 48 , we define this state as a P/pe hybrid configuration. These structural rearrangements are in good agreement with the FRET value observed for the neomycin-induced intermediate ribosome configuration (Fig. 2 and Supplementary Fig. 5 ) and provide key structural insights into events underpinning the process of subunit rotation.
Formation of the unlocked state, which precedes both substrate translocation and ribosome recycling, requires a 9° rotation of the small subunit that is accompanied by a lateral compression of the major groove of H69 (ref. 27) . Notably, neomycin binding to the rotated ribosome in the crystals reversed the compression of H69 (Fig. 4c) . The position of neomycin within the major groove of H69, buttressed by the interactions of ring IV with the phosphate of G1517 within h45 and the Watson-Crick face of U793 in h24 of the small subunit (Fig. 4d) , sterically blocks H69 compression. Thus, neomycin alters bridge B2 rearrangements that normally accompany the transition from the unrotated to the rotated state (Fig. 4c) , preventing movement of the ribosome into the fully rotated state. Concomitantly, h24 of 16S rRNA impedes P-site tRNA movement into its P/E hybrid position (Fig. 4e) , resulting in its intersubunit hybrid (P/pe) position.
These crystallographic data suggest that neomycin can allosterically inhibit global aspects of the translation mechanism through its interactions with the H69 binding site. Neomycin does this by preventing normal bridge B2 remodeling events that accompany the small-subunit rotation and the repositioning of tRNA into the P/E hybrid site that precede both substrate translocation and ribosome recycling 27, 36 . Neomycin-induced stabilization of the intermediate configuration also provides a structural rationale for its inhibition of tRNA selection, as this process probably requires an unrotated configuration of the ribosome. Collectively, these observations provide a compelling argument for a central role of dynamics in the translation mechanism and for the notion that productive-factor-binding interactions with the ribosome may operate through a conformational selection-type mechanism 17,32,49-51 .
Conformational selection and the translation mechanism
The synthesis phase of translation hinges on the cyclical binding of EF-G and elongation factor thermal unstable (EF-Tu) to overlapping sites at the leading edge of the ribosome 48, 52, 53 . Yet, despite the fact that the cellular concentrations of both elongation factors exceed their K m values for ribosome binding, EF-Tu and EF-G do not competitively inhibit translation. A simplified conformational selection model of the translation mechanism posits that the unrotated, locked configuration of the ribosome is competent to productively engage EF-Tu in a ternary complex with aa-tRNA and GTP, whereas the fully rotated, P/E hybrid ribosome configuration is competent to productively engage EF-G. Such a model predicts that intermediate configurations of subunit rotation should not productively bind either factor. Consistent with this notion, both EF-G and EF-Tu sterically clash with elements of the large and small subunits when docked to the intermediate ribosome configuration (Fig. 5a,b) . Direct smFRET measurements also showed that neomycin prevents productive elongation factor interactions at the 
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A site (Fig. 5c,d ). These data suggest that small-molecule antibiotics, such as neomycin, can effectively inhibit or alter the translation mechanism by allosterically controlling ribosome conformation and, thus, ribosome interactions with essential translation components.
DISCUSSION
The intrinsically dynamic nature of the ribosome enables the translating particle to spontaneously alternate between globally distinct functional configurations. The nature of these dynamics directly affects translation factor binding and translational activity. Correspondingly, the underlying energy landscape 22 of these dynamics must be considered as a central feature of translational control. Previous data supporting this conclusion include the observation that P-site tRNA deacylation after peptide-bond formation controls subunit rotation 23, 54 and that translation elongation processes may be regulated by the structural elasticity of the tRNA ligands of the ribosome 32, 41, 55 . We now show that neomycin binding at the base of H69 allosterically regulates ribosome dynamics and the mechanism of translation by controlling the process of subunit rotation. The observation of a second aminoglycoside binding site within intersubunit bridge B2 helps explain the pleiotropic effects of neomycinand, perhaps, related 2-DOS aminoglycosides-on the translation mechanism 1 . However, as the three-ring 4,6-linked 2-DOS aminoglycoside kanamycin does not lead to intermediate ribosome configurations, inhibitory effects associated with the H69 binding site may be restricted to aminoglycosides containing a ring IV substituent. This also highlights the potential for disease-associated H69 perturbations to allosterically control translation processes 56 . Future efforts should be aimed at exploring whether other small-molecule compounds target this site to inhibit the translation mechanism. Efforts must also be directed to understanding whether the bactericidal nature of aminoglycosides is tied to the binding of the drug to H69.
Miscoding effects alone are insufficient to explain the mechanism of aminoglycoside-induced cell killing 57, 58 ; rather, cell death is associated with elevated drug concentrations in the cell during late stages of drug influx and translational catastrophe 59 . In line with our smFRET subunit rotation data (Fig. 2b) , the functional studies presented here ( Fig. 1 and Supplementary Fig. 1 ) suggest that neomycin binding to H69 begins to block the essential translation reactions even at low concentrations (>10 nM). This observation implies that the effects of neomycin on subunit rotation through H69 may feature prominently in the mechanism of translation inhibition at the minimum inhibitory concentrations of wild-type cells (approximately 1.5-5 µM) 31, 60 . In this view, the partial cellular resistance to neomycin conferred by the A1408G mutation in the h44 decoding site may arise from a loss of miscoding-induced, late-stage drug influx into the cell, a synergistic loss of the drug binding to H69 as a result of h44 alterations or both. These models may be delineated by future investigations aimed at determining the intracellular concentrations of neomycin in wild-type and A1408G cells immediately before cell death. The physical proximity of h44 and H69 binding suggest that the functional coupling of these sites may be nontrivial. Investigations of this kind will not only enable a deeper understanding of the full potential of H69 as a drug target but also reveal whether the allosteric regulation of ribosome dynamics and conformation can be mediated in a species-specific manner as a means for therapeutic translation control.
METHODS
Methods and any associated references are available in the online version of the paper. 
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ONLINE METHODS
Generation of site-specifically labeled 30S subunits and 50S subunits. Ribosomal protein S13 was PCR cloned from E. coli strain K12 genomic DNA into the pPROEX HTb vector with a TEV-protease-cleavable histidine (His) 6 tag and a 12-residue peptide encoding the S6 epitope for the Sfp phosphopantetheinyl transferase reaction 62 (amino acid sequence, GDSLSWLLRLLN) fused at the N terminus (N-Sfp). After transformation of this plasmid into an E. coli ∆S13 knockout strain 63 , cells were cultured and ribosomes were harvested as previously described 49 . Pure 30S subunits were isolated by sucrose gradient centrifugation in a low-magnesium buffer (20 mM HEPES, pH 7.5, 50 mM KCl, 10 mM NH 4 Cl, 0.5 mM EDTA, 6 mM β-mercaptoethanol (BME) and 1 mM MgCl 2 ). 30S subunits containing Sfp-tagged S13 were isolated from this population by cobalt affinity chromatography (Clontech). Then, the Sfp tag was enzymatically labeled, and the His 6 tag was enzymatically removed in a buffer containing 20 mM HEPES, pH 7.5, 100 mM KCl, 10 mM MgCl 2 and 6 mM BME. Twenty micromolar N-Sfp-S13 30S subunits, 5 µM TEV protease, 250 µM Cy3-coenzyme A (CoA) and 25 µM Sfp enzyme were incubated for 24 h at 18 °C. Sfp enzyme, TEV protease and unbound Cy3-CoA were then removed by filtration over a 100K membrane (Millipore). Before 70S complex formation, ribosomes were buffer exchanged into Tris-polymix buffer 32 . 50S subunits labeled with Cy5-L1 (T202C) were prepared and purified as previously described 36 .
Preparation of L1 S13 FRET ribosome complexes with tRNA fMet or tRNA Phe in the P site. Cy3-S13 30S and Cy5-L1 50S subunits were heat activated at 42 °C for 10 min in Tris-polymix Mg 2+ buffer 32 . Ribosomes were then initiated with fMet-tRNA fMet or NAc-Phe-tRNA Phe , as previously described 32 .
Single-molecule L1 S13 FRET assay. All single-molecule FRET experiments were performed at room temperature in Tris-polymix with 5 mM Mg 2+ buffer, as previously described 49 , and in which oxygen scavenging and triplet-state quenching systems were used 64 . After surface immobilization 65 , the ribosome-bound, P-site tRNA was deacylated by incubation with 2 mM puromycin for 10 min at room temperature. The smFRET data were acquired by directly exciting the Cy3 fluorophore at 532 nm (LaserQuantum) while the Cy3 and Cy5 intensities were simultaneously recorded in Metamorph (Molecular Devices) with a 40-ms integration time. The data were analyzed in MATLAB (MathWorks) and plotted in Origin (OriginLab), as previously described 65 .
Ribosome purification and crystallization. Ribosomes lacking protein S1 were purified from E. coli strain MRE600 using sucrose gradient centrifugation, as previously described 66 . Ribosomes were crystallized at 18 °C using microbatch 96-well plates and buffers containing 4.0-5.0% 2-methyl-2,4-pentanediol (MPD), 4.1-4.5% PEG 8000, 4.0 mM MgCl 2 , 380 mM NH 4 Cl, 5.7 mM putrescine, 5.0 mM spermidine, 10 mM Tris, 40 mM MES, pH 6.5-7.0, and 0.25 mM EDTA. Ribosome complexes were formed by incubating 4 µM deacylated tRNA Phe and 8 µM mRNA of sequence 5′-GGCAAGGAGGUAAAAUUCUACAAA-3′ (Thermo Scientific) with 2 µM ribosomes at 37 °C for 15 min. Eight micromolar RRF was then added, and the samples were incubated for an additional 15 min at 37 °C. Before crystallization, samples were subjected to ultrafiltration to remove excess ligands.
Data collection and processing. Ribosome crystals were stabilized with crystallization buffer containing 7.0% MPD, 7.0% PEG 8000 and 24% PEG 400, pH 4.8, to allow cryo-cooling of the crystals to liquid nitrogen temperatures. During the last cryo-cooling step (PEG 400 24%), neomycin (Sigma-Aldrich) was added at a 100 µM concentration to the cryo-protection buffer, and crystals were incubated at 4 °C with neomycin containing cryo-protection buffer. After 2 h of incubation, the concentration of neomycin was reduced to 2 µM by cryo-protection buffer exchange, and crystals were frozen with liquid nitrogen after 1-4 d of incubation at 4 °C. Diffraction data were measured from crystals cooled to 100 K using 0.1-0.3° oscillations at the Advanced Light Source (beamlines 8.3.1 and 12.3.1), each of which is equipped with an ADSC Q315 area detector. Data were reduced using XDS 67 , yielding the statistics shown in Table 1 .
Molecular replacement and structure refinement. The two copies of the 70S ribosome in the crystallographic asymmetric unit were located using rigid-body refinement in PHENIX 68 of the well-ordered E. coli ribosome from the recent atomic-resolution structure determination 27 . The tRNAs were removed from the molecular replacement model to reduce possible model bias during refinement. Corrections to the resulting model were carried out in Coot 69 and side chain rotator tools in KiNG 70 . Refinement was carried out in PHENIX, including the use of pucker-specific target parameters. The resulting structural models were then refined using rounds of manual rebuilding in Coot or KiNG, as well as positional refinement in PHENIX, including the use of a new functionality for automatic assignment of hydrogen-bond restraints using the Saenger basepair types 71 . Electron density maps were generated from the PHENIX output directly. RNA rebuilding concentrated on the tRNAs, H69 and h44 (neomycin binding sites), and neomycin structures were inserted and refined by using Coot and PHENIX. Neomycin occupancies were determined by matching neomycin atomic displacement parameters to the mean value of neighboring rRNA, and then the group occupancy of each neomycin was refined in PHENIX. After final refinement, the Coot program tool 'Find ligand' was used to search meaningful (>3 s.d. above the mean) electron density features from F obs -F calc difference electron density maps with the structure of neomycin as the target. Using this approach, evidence for additional neomycin binding sites was found near A482 (H24), G551 (H25), G1157 (H41), U1240 (H46), A1858 (H68) and C2674 (H95) in 23S rRNA, and near C658 (h22), G902 (h27) and U1420 (h44) in 16S rRNA. However, the conformational change from the fully rotated to the intermediate ribosome configuration described here cannot be rationalized by neomycin binding at these sites.
Superpositions.
Comparisons to atomic-resolution structures of the ribosome were carried out by the 'pair_fit' command in PyMOL 61 . From the chosen atom pairs, disordered or moving regions of 23S rRNA were not used (for example, the L1 stalk, the L7/L12 stalk, H38 and H69) in the superpositions. Superpositions were performed using ribose C1′ positions or phosphorus atoms in nucleotides.
The angles of rotation of the 30S subunit domains were calculated essentially as described previously 27, 37 . Angles given for the rotation of the head domain were calculated from 30S subunit structures superimposed by means of their platform domains. A rotation of 0° is defined as centering the head domain over the 30S P site, as seen in the structure of the unrotated ribosome 27 . Superpositions of P/P, P/pe and P/E tRNAs used the C1′ atoms of nucleotides 31-39 in the anticodon stem loop 27 . The comparisons of tRNA bending angles used the glycosidic bond of position 31 near the end of the anticodon stem loop and the glycosidic bond of nucleotide 63 in the superimposed tRNAs 27 . The bending angles calculated in this way were 24° for P/P tRNA compared to P/pe tRNA and 14° for P/pe tRNA compared to P/E tRNA. Single-molecule tRNA incorporation assay. The process of tRNA selection on the ribosome was monitored using single-molecule FRET by stropped-flow injection of a 10 nM solution of ternary complex (EF-Tu·GTP·aa-tRNA) containing Phe-tRNA Phe (Cy5-acp 3 U47) to surface-immobilized ribosome complexes containing deacylated tRNA fMet (Cy3-s 4 U8) in the P site, as previously described 29 . Fluorescence and FRET traces were extracted from the video and selected for analysis using automated analysis software implemented in MATLAB (MathWorks) using the segmental k-means algorithm 72 . Complete accommodation of Phe-tRNA Phe into the A site was marked by the first observation of a 400-ms dwell in a high (0.55 ± 0.61) FRET state, structurally assigned to the classical pre-translocation complex configuration through previous investigations 29 . Individual experiments, in which approximately 100 accommodation events were obtained, were performed in triplicate. The mean extent of accommodation and s.d. are plotted as a function of time. Wild-type and mutant ribosomes for these experiments were purified as previously described 17 .
Single-molecule translocation assay. Fluorescence-based, single-molecule translocation assays were carried out as previously described 32 on either wildtype or A1408G mutant pre-translocation ribosome complexes. Experiments were performed in Tris-polymix buffer (pH 7.5, 5 mM Mg(OAc) 2 ) and analyzed as previously described 32, 49 , plotting the fraction of translocating molecules as a function of time.
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